Oliver Luxxe Assets LLC

Position in GANX — Gain Therapeutics, Inc.

CIK 1666239 GLADSTONE, NJ

Position in GANX

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$41,107

+$1,822 QoQ

Shares Held

20,250

0.0% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#29

of 49 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Oliver Luxxe Assets LLC holds $10,072,172 across 5 Biotechnology names. GANX ranks #5 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	18,860	$4,544,694
2	HALO	Halozyme Therapeutics, Inc.	33,014	$2,584,005
3			49,744	$1,563,453
4	INVA	Innoviva, Inc.	58,957	$1,338,913
5	GANX	Gain Therapeutics, Inc. This page	20,250	$41,107

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$41,107	20,250	0.0%	Shares	Sole	2026-07-09
2026-03-31	$39,285	20,250	0.0%	Shares	Sole	2026-04-08
2025-12-31	$65,205	20,250	—	Shares	Sole	2026-01-08
No filing history on record for this holder in this stock.